Andina Bottling-B
AKO.B
31.50
+0.95
+3.09%
Andina Bottling-B
US · AKO.B
#2173 by market cap
Listed 1970
31.50
+0.95
+3.09%
Live - 5344 symbols - heartbeat 90s ago
· 2026-10-07 19:54
After-hours
31.50
0.00%
- Market cap
- 4.97B
- P/E (TTM)i
- 17.62
- P/Bi
- 3.69
- EPSi
- 1.66
- Div yieldi
- 1.24%
- 52W posi
- 91%
Reader sentiment
Are you bullish or bearish on AKO.B?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.00, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.74% YoY
Margins
- Gross margin
- 39.08%
- Operating margin
- 13.53%
- Net margin
- 8.03%
Key ratios & quality
- Enterprise valuei
- 804.93B
- PEG ratioi
- 0.61
- Altman Z-Scorei
- 2.00
PEG uses trailing P/E against the 3-year net income growth rate (28.89%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.67T | 1.78T | 1.70T | 2.22T | 2.66T | 2.62T | 3.22T | 3.34T |
| Gross profit | 704.89B | 730.68B | 675.78B | 841.34B | 1.03T | 1.02T | 1.28T | 1.31T |
| Selling & admin expenses | 479.52B | 492.90B | 436.17B | 548.90B | 683.03B | 659.10B | 851.79B | 851.79B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 220.72B | 273.20B | 241.37B | 288.48B | 340.05B | 352.93B | 428.21B | 452.51B |
| Pretax profit | 153.02B | 236.41B | 178.02B | 203.21B | 232.80B | 260.51B | 368.04B | 380.63B |
| Tax | 55.56B | 61.17B | 54.91B | 46.18B | 104.34B | 85.99B | 133.39B | 110.16B |
| Net profit | 97.45B | 175.25B | 123.12B | 157.03B | 128.46B | 174.51B | 234.64B | 270.48B |
| Basic EPS | 583 | 1.05K | 737 | 981 | 758 | 1.03K | 1.40K | 1.62K |
| Diluted EPS | 583.20 | 1,048.74 | 736.50 | 980.58 | 757.62 | 1,034.94 | 1,404.54 | 1,622.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 888.18B | 738.15B | 800.36B | 951.68B | 924.26B | 820.09B |
| Gross profit | 358.00B | 279.84B | 301.92B | 383.18B | 379.04B | 319.18B |
| Selling & admin expenses | 225.19B | 199.97B | 209.99B | 228.06B | 230.07B | 225.94B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 130.41B | 73.97B | 91.14B | 155.28B | 147.32B | 87.32B |
| Pretax profit | 115.68B | 58.82B | 82.88B | 130.10B | 139.13B | 64.22B |
| Tax | 36.00B | 22.08B | 25.30B | 28.37B | 38.77B | 26.78B |
| Net profit | 79.68B | 36.73B | 57.58B | 101.73B | 100.36B | 37.44B |
| Basic EPS | 502 | 225 | 345 | 654 | 629 | 225 |
| Diluted EPS | 502.14 | 224.76 | 345.18 | 654.00 | 629.16 | 224.94 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 481.59B | 533.47B | 797.30B | 990.99B | 1.16T | 981.77B | 1.01T | 1.03T |
| Cash & ST investments | 138.22B | 157.92B | 449.84B | 499.78B | 384.52B | 369.87B | 321.38B | 341.86B |
| Inventory | 151.32B | 147.64B | 127.97B | 191.35B | 245.89B | 233.05B | 299.97B | 304.55B |
| Total assets | 2.21T | 2.39T | 2.45T | 2.95T | 3.01T | 2.92T | 3.29T | 3.42T |
| Total current liabilities | 419.86B | 411.66B | 378.06B | 529.57B | 949.25B | 692.87B | 906.14B | 730.41B |
| Short-term debt | 43.74B | 29.06B | 25.22B | 33.60B | 348.56B | 38.91B | 95.83B | 45.25B |
| Long-term debt | 702.77B | 719.87B | 922.92B | 1.02T | 776.73B | 967.06B | 1.00T | 1.10T |
| Total liabilities | 1,350,789,946,000.00 | 1,422,044,475,000.00 | 1,616,503,809,000.00 | 1,844,693,088,000.00 | 2,127,297,955,000.00 | 2,000,535,475,000.00 | 2,276,707,253,000.00 | 2,223,851,570,000.00 |
| Total equity | 863.71B | 968.90B | 831.56B | 1.10T | 883.40B | 920.99B | 1.01T | 1.20T |
| Retained earnings | 462.22B | 600.92B | 654.17B | 768.12B | 716.98B | 769.31B | 891.75B | 1.17T |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 851.53B | 818.12B | 958.88B | 1.03T | 1.06T | 996.92B |
| Cash & ST investments | 208.48B | 207.19B | 282.83B | 341.86B | 372.01B | 368.85B |
| Inventory | 308.80B | 309.59B | 325.79B | 304.55B | 334.27B | 328.41B |
| Total assets | 3.12T | 3.11T | 3.38T | 3.42T | 3.54T | 3.49T |
| Total current liabilities | 663.23B | 617.58B | 699.47B | 730.41B | 633.54B | 618.19B |
| Short-term debt | 81.31B | 91.88B | 47.83B | 45.25B | 38.31B | 44.02B |
| Long-term debt | 991.24B | 1.00T | 1.12T | 1.10T | 1.10T | 1.11T |
| Total liabilities | 2,045,883,750,000.00 | 2,004,051,933,000.00 | 2,210,830,758,000.00 | 2,223,851,570,000.00 | 2,132,956,921,000.00 | 2,133,236,011,000.00 |
| Total equity | 1.07T | 1.11T | 1.17T | 1.20T | 1.41T | 1.36T |
| Retained earnings | 991.81B | 1.05T | 1.08T | 1.17T | 1.30T | 1.25T |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- | -- | -- |
| Free cash flow | 114.22B | 144.02B | 192.69B | 161.03B | 210.75B | 174.12B | 65.70B | 183.31B |
| Dividends paid | -87.54B | -86.27B | -99.99B | -106.35B | -274.32B | -165.88B | -158.41B | -195.89B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 137.54B | 157.57B | 309.53B | 304.31B | 291.68B | 303.68B | 248.90B | 296.54B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 37.33B | 7.11B | 9.62B | 129.23B | 35.41B | 107.45B |
| Dividends paid | -140.14B | -692.63M | -141.28M | -54.92B | 0 | -102.47B |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 208.48B | 207.19B | 282.83B | 296.54B | 325.67B | 322.08B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.82 | 19.38 | 13.86 | 16.39 | 13.00 | 19.69 | 24.98 | 25.18 |
| ROA %i | 4.46 | 7.54 | 5.04 | 5.74 | 4.21 | 5.78 | 7.49 | 8.01 |
| ROIC %i | 8.27 | 12.06 | 8.53 | 9.79 | 6.87 | 9.94 | 13.00 | 13.85 |
| 5-year avg ROE %i | 10.70 | 13.39 | 14.13 | 15.22 | 14.89 | 16.47 | 17.58 | 19.85 |
| EBIT margin %i | 12.44 | 15.51 | 13.26 | 11.45 | 10.86 | 12.25 | 13.35 | 13.27 |
| FCF / sales %i | 6.83 | 8.10 | 11.35 | 7.26 | 7.93 | 6.65 | 2.04 | 5.48 |
| Current ratioi | 1.15 | 1.30 | 2.11 | 1.87 | 1.22 | 1.42 | 1.12 | 1.41 |
| Quick ratioi | 0.77 | 0.90 | 1.74 | 1.49 | 0.76 | 1.05 | 0.75 | 0.97 |
| Debt / assetsi | 34.33 | 32.30 | 39.36 | 36.48 | 37.90 | 35.28 | 34.05 | 33.93 |
| LT debt / equityi | 84.92 | 78.36 | 115.67 | 96.74 | 92.68 | 111.91 | 104.95 | 96.35 |
| Interest coveragei | 3.78 | 6.99 | 4.78 | 5.01 | 5.18 | 5.32 | 6.89 | 7.01 |
| Revenue CAGR (3Y) %i | -3.77 | 0.03 | -2.79 | 9.84 | 14.30 | 15.53 | 13.30 | 7.98 |
| Net income CAGR (3Y) %i | 3.21 | 24.27 | 1.16 | 16.99 | -10.27 | 12.01 | 14.57 | 28.89 |
| FCF CAGR (3Y) %i | -9.19 | 14.78 | 42.08 | 12.13 | 13.53 | -3.32 | -25.83 | -4.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.37 | 24.10 | 25.47 | 25.18 | 24.05 | 24.26 |
| ROA %i | 7.72 | 8.27 | 8.37 | 8.01 | 8.67 | 8.78 |
| ROIC %i | 12.75 | 13.54 | 13.97 | 13.85 | 13.91 | 13.81 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.19 | 13.28 | 13.75 | 13.27 | 13.79 | 13.63 |
| FCF / sales %i | 2.81 | 3.33 | 3.29 | 5.48 | 5.37 | 8.10 |
| Current ratioi | 1.28 | 1.32 | 1.37 | 1.41 | 1.67 | 1.61 |
| Quick ratioi | 0.77 | 0.79 | 0.87 | 0.97 | 1.10 | 1.03 |
| Debt / assetsi | 35.04 | 35.80 | 35.11 | 33.93 | 32.80 | 33.65 |
| LT debt / equityi | 97.75 | 95.43 | 100.45 | 96.35 | 82.17 | 85.74 |
| Interest coveragei | 6.79 | 6.79 | 7.23 | 7.01 | 7.49 | 7.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.